Merus (MRUS) Short Interest Ratio & Short Volume → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free MRUS Stock Alerts $47.09 -1.64 (-3.37%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Merus Short Interest DataCurrent Short Volume3,290,000 sharesPrevious Short Volume3,440,000 sharesChange Vs. Previous Month-4.36%Dollar Volume Sold Short$135.78 millionShort Interest Ratio / Days to Cover5.7Last Record DateApril 15, 2024Outstanding Shares58,690,000 sharesPercentage of Shares Shorted5.61%Today's Trading Volume822,256 sharesAverage Trading Volume602,318 sharesToday's Volume Vs. Average137% Short Selling Merus ? Sign up to receive the latest short interest report for Merus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRUS Short Interest Over TimeMRUS Days to Cover Over TimeMRUS Percentage of Float Shorted Over Time Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. Merus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,290,000 shares $135.78 million -4.4%N/A5.7 $41.27 3/31/20243,440,000 shares $154.90 million -16.1%N/A5.8 $45.03 3/15/20244,100,000 shares $179.99 million -8.1%N/A7.1 $43.90 2/29/20244,460,000 shares $216.22 million -6.1%N/A8 $48.48 2/15/20244,750,000 shares $206.48 million +2.4%N/A8.9 $43.47 1/31/20244,640,000 shares $165.56 million -1.1%N/A10 $35.68 Get the Latest News and Ratings for MRUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merus and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,690,000 shares $152.85 million -14.4%N/A10.3 $32.59 12/31/20235,480,000 shares $150.70 million -2.3%N/A12.7 $27.50 12/15/20235,610,000 shares $141.60 million -12.5%N/A13.1 $25.24 11/30/20236,410,000 shares $158.58 million -2.3%N/A15.9 $24.74 11/15/20236,560,000 shares $157.24 million +0.3%N/A19.1 $23.97 10/31/20236,540,000 shares $131.52 million +28.0%N/A17.8 $20.11 10/15/20235,110,000 shares $107.82 million +9.9%N/A15.3 $21.10 9/30/20234,650,000 shares $109.65 million +8.1%N/A16.7 $23.58 9/15/20234,300,000 shares $104.79 million +0.2%N/A17.2 $24.37 8/31/20234,290,000 shares $95.97 million +5.7%N/A16.8 $22.37 8/15/20234,060,000 shares $87.66 million -2.2%N/A16.4 $21.59 7/31/20234,150,000 shares $108.90 million -2.8%N/A14.9 $26.24 7/15/20234,270,000 shares $116.53 million -4.5%11.9%13.5 $27.29 6/30/20234,470,000 shares $117.70 million -8.2%12.4%10.2 $26.33 6/15/20234,870,000 shares $129.88 million -1.4%13.5%10.4 $26.67 5/31/20234,940,000 shares $107.30 million +1.4%13.7%11 $21.72 5/15/20234,870,000 shares $102.08 million +7.5%13.5%10.7 $20.96 4/30/20234,530,000 shares $86.89 million +42.9%12.5%10.6 $19.18 4/15/20233,170,000 shares $68.95 million +6.0%8.8%7.8 $21.75 3/31/20232,990,000 shares $55.02 million +4.9%8.3%10.5 $18.40 3/15/20232,850,000 shares $57.80 million +2.9%7.8%11.9 $20.28 2/28/20232,770,000 shares $52.82 million -1.1%7.6%11.9 $19.07 2/15/20232,800,000 shares $52.11 million -2.8%7.7%12.8 $18.61 1/31/20232,880,000 shares $44.93 million -3.4%7.8%12.7 $15.60 1/15/20232,980,000 shares $45.98 million -1.3%N/A10.2 $15.43 12/30/20223,020,000 shares $46.72 million +13.5%N/A9.9 $15.47 12/15/20222,660,000 shares $35.32 million -4.0%N/A8.3 $13.28 11/30/20222,770,000 shares $42.52 million -3.5%N/A8.3 $15.35 11/15/20222,870,000 shares $52.61 million -1.7%N/A8.7 $18.33 10/31/20222,920,000 shares $59.86 million -1.0%8.4%8.9 $20.50 10/15/20222,950,000 shares $64.90 million +7.3%8.6%11.9 $22.00 9/30/20222,750,000 shares $55.08 million +10.0%8.0%10.5 $20.03 9/15/20222,500,000 shares $59.15 million +2.5%7.3%8.4 $23.66 8/31/20222,440,000 shares $57.78 million +0.8%7.2%8.7 $23.68BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> MRUS Short Interest - Frequently Asked Questions What is Merus' current short interest? Short interest is the volume of Merus shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,290,000 shares of MRUS short. Learn More on Merus' current short interest. What is a good short interest ratio for Merus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRUS shares currently have a short interest ratio of 6.0. Learn More on Merus's short interest ratio. Is Merus' short interest increasing or decreasing? Merus saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 3,290,000 shares, a decrease of 4.4% from the previous total of 3,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Merus' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Merus: ACADIA Pharmaceuticals Inc. (6.76%), MoonLake Immunotherapeutics (15.38%), Bausch Health Companies Inc. (5.81%), MorphoSys AG (1.02%), TG Therapeutics, Inc. (25.55%), Amicus Therapeutics, Inc. (10.57%), Arrowhead Pharmaceuticals, Inc. (7.16%), Corcept Therapeutics Incorporated (23.68%), Janux Therapeutics, Inc. (9.99%), IDEAYA Biosciences, Inc. (14.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Merus stock? Short selling MRUS is an investing strategy that aims to generate trading profit from Merus as its price is falling. MRUS shares are trading down $1.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Merus? A short squeeze for Merus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRUS, which in turn drives the price of the stock up even further. How often is Merus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRUS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ACADIA Pharmaceuticals Short Interest Data MoonLake Immunotherapeutics Short Interest Data Bausch Health Companies Short Interest Data MorphoSys Short Interest Data TG Therapeutics Short Interest Data Amicus Therapeutics Short Interest Data Arrowhead Pharmaceuticals Short Interest Data Corcept Therapeutics Short Interest Data Janux Therapeutics Short Interest Data IDEAYA Biosciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRUS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings